Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.

The “off-the-shelf” CAR T-cell therapy CTD402 will be evaluated in a phase 1b/2 trial for patients with T-cell acute ...

Vericel's FDA-approved regenerative medicine products and robust pipeline signal strong growth potential, with zero debt and ...

(NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today provided an update on its subsidiary, Adimune, Inc., (“Adimune”) ...

Two of the Dow Jones Industrial Average's 30 components make for no-brainer buys, while another brand-name member continues ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

Q4 2024 Earnings Call Transcript March 5, 2025 Zymeworks Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, ...

In today’s fast-evolving global economy, Asia has become a reliable destination for high-tech manufacturing and ...

Talent pool access due to close proximity to Basel, a renowned pharma and biotech hub at the crossroads of Germany, France, and Switzerland, ensuring access to highly skilled professionals.

Governor Charles Soludo of Anambra State condemned native doctors for misleading youths with promises of supernatural ...